Home > News > Delivering on Nano's Promise
October 9th, 2006
Delivering on Nano's Promise
Abstract:
Several nanotechnology-enabled drugs are on the market and researchers are investigating the next generation of nanoparticles for drug delivery.
In 1995, several years before the word nanotechnology began creating a buzz, Doxil (doxorubicin HCL liposome injection) received accelerated approval for the treatment of chemotherapy-refractive AIDS-related Kaposi’s sarcoma. The fact that Doxil was a reformulation of an earlier drug, Adriamycin (doxorubicin), did not make it unique. What did, however, was how it was reformulated by Doxil’s developer, Alza Corp., Mountain View, Calif., a subsidiary of Johnson & Johnson, New Brunswick, N.J.
Source:
dddmag.com
Bookmark:
| Related News Press |
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Profiles
Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||